Moderna stock rises more than 600% this year
MRNA Moderna Inc
$216.25 +1.17%
View chart & analysis → - 1Moderna stock has recorded a year-to-date increase of more than 600%.
- 2Moderna stock rose 18% last week.
- 3Moderna and Merck reported Phase 3 clinical trial results for a personalized mRNA cancer vaccine in August.
So what's the key point?
Moderna's stock price has risen by more than 600% this year. There is an expectation that the stock will rise further as cancer vaccine trial results are due to be released.
Source Quartz · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.